SelenBio
Early Stage
antibacterial technology for a wide variety of use cases
Overview
Raised: $147,972
Total Commitments ($USD)
Platform
Netcapital
Start Date
10/02/2019
Close Date
04/28/2020
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment
$4
Security Type
Equity - Common
Series
Seed
SEC Filing Type
RegCF
Price Per Share
$4.00
Pre-Money Valuation
$19,621,196
Rolling Commitments ($USD)
Status
Funded
Reporting Date
05/02/2020
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$711
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
High
Capital Intensity
High
SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$12,142 |
$1,039 |
|
COGS |
$11,785 |
$871 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-453,939 |
$-134,867 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$550,794 |
$104,479 |
|
Accounts Receivable |
$153 |
$213 |
|
Total Assets |
$1,044,713 |
$475,538 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Financials as of: 10/02/2019
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.